MedPath

Smoking Cessation among Patients with Coronary Heart disease.

Completed
Conditions
'coronary heart disease' and 'smoking cessation' 'coronaire hartziekte' en 'stoppen met roken'
Registration Number
NL-OMON20676
Lead Sponsor
Open Universiteit Nederland, Universiteit Maastricht en Stichting Volksgezondheid en Roken (STIVORO)
Brief Summary

Berndt, N.C., Bolman, C., Lechner, L., Mudde, A., de Vries, H. (2012). Effectiveness of two intensive treatment methods for smoking cessation and relapse prevention in patients with coronary heart disease: study protocol and baseline description. BMC Cardiovascular Disorders, 12 (1), 33. <br><br> http://www.biomedcentral.com/content/pdf/1471-2261-12-33.pdf

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
894
Inclusion Criteria

Patients who are admitted with coronary heart disease at cardiac wards and smoked at least five cigarettes a week prior to hospital admission will be recruted. Inclusion criteria are:

1. Stable cardiac situation;

Exclusion Criteria

Exlusion criteria are:

1. Unstable cardiac situation;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome will be point prevalence abstinence from smoking (PPA) after 6 and 12 months. PPA is considered to be the most sensitive and valid measure of smoking cessation.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath